Department of Pathophysiology and Gerontology, Medical School, University of Pécs, Hungary.
Exp Gerontol. 2013 Nov;48(11):1180-8. doi: 10.1016/j.exger.2013.07.006. Epub 2013 Jul 19.
Cholecystokinin (CCK) is anorexic, irrespective whether it is applied intraperitoneally (IP) or intracerebroventricularly (ICV) in male Wistar rats. The metabolic effects depend on the route of administration: by the IP route it elicits hypothermia (presumably by type-1 receptors, CCK1R-s), while ICV administration is followed by fever-like hypermetabolism and hyperthermia via activation of CCK2R-s, which latter response seems to be most important in the postprandial (compensatory) hypermetabolism. The efficacy of the IP injected CCK varies with age: it causes strong anorexia in young adult 4 and 6-months old and again in old rats (aged 18-24 months), but the middle-aged (12-month old) ones seem to be resistant to this effect. Such pattern of effects may contribute to the explanation of age-related obesity observed in middle-aged animals as well as to the aging anorexia and loss of body weight in old ones. Diet-induced obesity accelerates the appearance of CCK-resistance as well as the return of high sensitivity to CCK in further aging, while chronic calorie-restriction prevents the development of resistance, as if the speed of the age-related regulatory changes was altered by the nutritional state. The effects of ICV applied CCK also change with age: the characteristic anorexic and hypermetabolic/hyperthermic effects can be observed in young adult rats, but the effects gradually and monotonically decline with age and disappear by the old age of 24 months. These disparate age-related patterns of CCK efficacy upon peripheral or central administration routes may indicate that although both peripheral and central CCKR-s exert anorexic effects, they may have dissimilar roles in the regulation of overall energy balance.
胆囊收缩素(CCK)无论是通过腹腔内(IP)还是脑室内(ICV)给药,对雄性 Wistar 大鼠都具有厌食作用。其代谢作用取决于给药途径:通过 IP 途径,它会引起体温降低(推测是通过 1 型受体,CCK1R-s),而 ICV 给药后则会出现发热样高代谢和体温升高,这是通过激活 CCK2R-s 引起的,后者的反应似乎在餐后(代偿性)高代谢中最为重要。IP 注射的 CCK 的功效会随年龄而变化:它会在年轻的成年 4 个月和 6 个月龄大鼠以及老年大鼠(18-24 个月龄)中引起强烈的厌食症,但中年(12 个月龄)大鼠似乎对这种作用有抵抗力。这种作用模式可能有助于解释中年动物中观察到的与年龄相关的肥胖现象,以及老年动物中出现的厌食和体重减轻现象。饮食诱导的肥胖会加速 CCK 抵抗的出现,以及进一步衰老时对 CCK 敏感性的恢复,而慢性热量限制则可防止抵抗的发展,就好像营养状态改变了与年龄相关的调节变化的速度。ICV 应用 CCK 的作用也会随年龄而变化:在年轻的成年大鼠中可以观察到特征性的厌食和高代谢/体温升高作用,但随着年龄的增长,这些作用逐渐且单调地下降,并在 24 个月龄的老年时消失。外周或中枢给药途径的 CCK 功效的这些不同的年龄相关模式可能表明,尽管外周和中枢 CCKR-s 都具有厌食作用,但它们在调节整体能量平衡方面可能具有不同的作用。